Amanote Research
Register
Sign In
Functionally Biased D2R Antagonists: Targeting the Arrestin Pathway to Improve Antipsychotic Treatment
doi 10.1021/acschembio.8b00168.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Targeting the Hedgehog Pathway to Mitigate Treatment Resistance
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Β-Arrestin–biased Signaling Mediates Memory Reconsolidation
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Targeting the CXCL12/CXCR4 Pathway and Myeloid Cells to Improve Radiation Treatment of Locally Advanced Cervical Cancer
International Journal of Cancer
Cancer Research
Oncology
Novel and Potent Dopamine D2 Receptor (D2R) Go-Protein Biased Agonists
ACS Pharmacology & Translational Science
Molecular Mechanisms of Fentanyl Mediated Β-Arrestin Biased Signaling
Beta-Arrestin Biased Signaling at a Class a GPCR: Modeling the ORG27569 Induced CB1/Beta-Arrestin 1 Complex
Biophysical Journal
Biophysics
Β-Arrestin–biased Signaling Through the Β2-Adrenergic Receptor Promotes Cardiomyocyte Contraction
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Targeting Tyrosine Hydroxylase to Improve Bradykinesia
Targeting the BDNF/TrkB Pathway for the Treatment of Tumors (Review)
Oncology Letters
Cancer Research
Oncology
